Anti-Js(b) has not been reported to cause severe hemolytic disease of
the newborn requiring intrauterine evaluation and treatment. We now re
port on such a patient with high-titered anti-Js(b) causing fetal hydr
ops with demise in one pregnancy, followed by a pregnancy treated with
multiple intrauterine fetal transfusions.